Advertisement

Molecular Medicine

, Volume 17, Issue 5–6, pp 523–532 | Cite as

Involvement of Leptin Receptor Long Isoform (LepRb)-STAT3 Signaling Pathway in Brain Fat Mass- and Obesity-Associated (FTO) Downregulation during Energy Restriction

  • Pei Wang
  • Feng-Jiao Yang
  • Hui Du
  • Yun-Feng Guan
  • Tian-Ying Xu
  • Xue-Wen Xu
  • Ding-Feng Su
  • Chao-Yu Miao
Research Article

Abstract

Obesity is an important risk factor for cardiovascular disease, diabetes and certain cancers. The fat mass- and obesity-associated (FTO) gene is tightly associated with the pathophysiology of obesity, whereas the exact role of FTO remains poorly understood. Here, we investigated the alternations of FTO mRNA and protein expression in the peripheral metabolic tissues and the brain upon energy restriction (ER) and explored the involvement of the leptin signaling pathway in FTO regulation under ER status. ER decreased the FTO mRNA and protein expression in hypothalamus and brainstem but not in periphery. Using double-immunofluorescence staining, FTO was found to be colocalized with the leptin receptor long isoform (LepRb) in arcuate nucleus of hypothalamus and the nucleus of the solitary tract. In LepRb mutant db/db mice, the FTO downregulation in brain and body weight reduction induced by ER were completely abolished. The enhanced phosphorylation of signal transducer and activator of transcription 3 (STAT3) induced by ER was also impaired in db/db mice. Moreover, leptin directly activated the STAT3 signaling pathway and downregulated FTO in in vitro arcuate nucleus of hypothalamus cultures and in vivo wild-type mice but not db/db mice. Thus, our results provide the first evidence that the LepRb-STAT3 signaling pathway is involved in the brain FTO downregulation during ER.

Notes

Acknowledgments

This work was supported by grants from the National Natural Science Foundation of China for Distinguished Young Scholars to C-Y Miao (30525045), the National Basic Research Program of China to C-Y Miao (2009CB521902), the National Science and Technology Major Project to C-Y Miao (2009ZX09303-002), the Program of Shanghai Subject Chief Scientist to C-Y Miao (10XD1405300), the Open Funds of the Shanghai Key Laboratory of Vascular Biology to P Wang (GXY2009001005) and the “Shizhen Project” of the School of Pharmacy, Second Military Medical University, China, to PWang.

References

  1. 1.
    Dina C, et al. (2007) Variation in FTO contributes to childhood obesity and severe adult obesity. Nat. Genet. 39:724–6.CrossRefGoogle Scholar
  2. 2.
    Frayling TM, et al. (2007) A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science. 316:889–94.CrossRefPubMedCentralGoogle Scholar
  3. 3.
    Scuteri A, et al. (2007) Genome-wide association scan shows genetic variants in the FTO gene are associated with obesity-related traits. PLoS Genet. 3:1200–10.CrossRefGoogle Scholar
  4. 4.
    Wardle J, et al. (2008) Obesity associated genetic variation in FTO is associated with diminished satiety. J. Clin. Endocrinol. Metab. 93:3640–3.CrossRefGoogle Scholar
  5. 5.
    Hotta K, et al. (2008) Variations in the FTO gene are associated with severe obesity in the Japanese. J. Hum. Genet. 53:546–53.CrossRefPubMedCentralGoogle Scholar
  6. 6.
    Tan JT, et al. (2008) FTO variants are associated with obesity in the Chinese and Malay populations in Singapore. Diabetes. 57:2851–7.CrossRefPubMedCentralGoogle Scholar
  7. 7.
    Field SF, Howson JMM, Walker NM, Dunger DB, Todd JA. (2007) Analysis of the obesity gene FTO in 14,803 type 1 diabetes cases and controls. Diabetologia. 50:2218–20.CrossRefPubMedCentralGoogle Scholar
  8. 8.
    Haupt A, et al. (2008) Impact of variation in the FTO gene on whole body fat distribution, ectopic fat, and weight loss. Obesity (Silver Spring). 16:1969–72.CrossRefGoogle Scholar
  9. 9.
    Mitchell JA, et al. (2010) FTO genotype and the weight loss benefits of moderate intensity exercise. Obesity (Silver Spring). 18:641–3.CrossRefGoogle Scholar
  10. 10.
    Gerken T, et al. (2007) The obesity-associated FTO gene encodes a 2-oxoglutarate-dependent nucleic acid demethylase. Science. 318:1469–72.CrossRefPubMedCentralGoogle Scholar
  11. 11.
    Stratigopoulos G, et al. (2008) Regulation of Fto/Ftm gene expression in mice and humans. Am. J. Physiol. Regul Integr. Comp. Physiol 294:R1185–96.CrossRefPubMedCentralGoogle Scholar
  12. 12.
    Fredriksson R, et al. (2008) The obesity gene, FTO, is of ancient origin, up-regulated during food deprivation and expressed in neurons of feeding-related nuclei of the brain. Endocrinology. 149:2062–71.CrossRefGoogle Scholar
  13. 13.
    Villanueva EC, Myers MG Jr. (2008) Leptin receptor signaling and the regulation of mammalian physiology. Int. J. Obes. (Lond.). 32 Suppl 7:S8–12.CrossRefGoogle Scholar
  14. 14.
    Morton GJ, Cummings DE, Baskin DG, Barsh GS, Schwartz MW. (2006) Central nervous system control of food intake and body weight. Nature. 443:289–95.CrossRefPubMedCentralGoogle Scholar
  15. 15.
    Friedman JM, Halaas JL. (1998) Leptin and the regulation of body weight in mammals. Nature. 395:763–70.CrossRefGoogle Scholar
  16. 16.
    Ahima RS, Flier JS. (2000) Leptin. Annu. Rev. Physiol. 62:413–37.CrossRefGoogle Scholar
  17. 17.
    Lee GH, et al. (1996) Abnormal splicing of the leptin receptor in diabetic mice. Nature. 379:632–5.CrossRefGoogle Scholar
  18. 18.
    Fernandez-Galaz C, et al. (2002) Long-term food restriction prevents ageing-associated central leptin resistance in Wistar rats. Diabetologia. 45:997–1003.CrossRefGoogle Scholar
  19. 19.
    Wilsey J, Scarpace PJ. (2004) Caloric restriction reverses the deficits in leptin receptor protein and leptin signaling capacity associated with diet-induced obesity: role of leptin in the regulation of hypothalamic long-form leptin receptor expression. J. Endocrinol. 181:297–306.CrossRefGoogle Scholar
  20. 20.
    Andreasen CH, et al. (2008) Low physical activity accentuates the effect of the FTO rs9939609 polymorphism on body fat accumulation. Diabetes. 57:95–101.CrossRefGoogle Scholar
  21. 21.
    Do R, et al. (2008) Genetic variants of FTO influence adiposity, insulin sensitivity, leptin levels, and resting metabolic rate in the Quebec Family Study. Diabetes. 57:1147–50.CrossRefGoogle Scholar
  22. 22.
    Labayen I, et al. (2010) Association between the FTO rs9939609 polymorphism and leptin in European adolescents: a possible link with energy balance control. The HELENA study. Int. J. Obes. (Lond.). 2010, Oct 26 [Epub ahead of print].Google Scholar
  23. 23.
    Glowinski J, Iversen LL. (1966) Regional studies of catecholamines in the rat brain. I. The disposition of [3H]norepinephrine, [3H]dopamine and [3H]dopa in various regions of the brain. J. Neurochem. 13:655–69.CrossRefGoogle Scholar
  24. 24.
    Andrews AM, Murphy DL. (1993) Fluoxetine and desipramine selectively attenuate 2’-NH2-MPTP-induced depletions in serotonin and nor-epinephrine. Eur. J. Pharmacol. 250:215–21.CrossRefGoogle Scholar
  25. 25.
    Wang P, et al. (2010) Visfatin is associated with lipid metabolic abnormalities in Lyon hypertensive rats. Clin. Exp. Pharmacol. Physiol. 37:894–9.CrossRefGoogle Scholar
  26. 26.
    Xu TY, et al. (2010) 4-Phenyl butyric acid does not generally reduce glucose levels in rodent models of diabetes. Clin. Exp. Pharmacol. Physiol. 37:441–6.CrossRefGoogle Scholar
  27. 27.
    Spano D, et al. (2010) Galectin-1 and its involvement in hepatocellular carcinoma aggressiveness. Mol. Med. 16:102–15.CrossRefGoogle Scholar
  28. 28.
    Hegde A, et al. (2010) Substance P in polymicrobial sepsis: molecular fingerprint of lung injury in preprotachykinin-A-/- mice. Mol. Med. 16:188–98.PubMedPubMedCentralGoogle Scholar
  29. 29.
    Wang P, et al. (2009) Perivascular adipose tissue-derived visfatin is a vascular smooth muscle cell growth factor: role of nicotinamide mononu-cleotide. Cardiovasc. Res. 81:370–80.CrossRefGoogle Scholar
  30. 30.
    Wang P, et al. (2011) Nicotinamide phosphori-bosyltransferase protects against ischemic stroke through SIRT1-dependent adenosine monophosphate-activated kinase pathway. Ann. Neurology. 69:360–74.CrossRefGoogle Scholar
  31. 31.
    Szwaya J, et al. (2007) A novel platform for accelerated pharmacodynamic profiling for lead optimization of anticancer drug candidates. J. Biomol Screen. 12:159–66.CrossRefGoogle Scholar
  32. 32.
    Bouret SG, Draper SJ, Simerly RB. (2004) Trophic action of leptin on hypothalamic neurons that regulate feeding. Science. 304:108–10.CrossRefGoogle Scholar
  33. 33.
    Annis CM, Edmond J, Robertson RT. (1990) A chemically-defined medium for organotypic slice cultures. J. Neurosci. Methods. 32:63–70.CrossRefGoogle Scholar
  34. 34.
    El-Haschimi K, Pierroz DD, Hileman SM, Bjorbaek C, Flier JS. (2000) Two defects contribute to hypothalamic leptin resistance in mice with diet-induced obesity. J. Clin. Invest. 105:1827–32.CrossRefPubMedCentralGoogle Scholar
  35. 35.
    Fischer J, et al. (2009) Inactivation of the Fto gene protects from obesity. Nature. 458:894–8.CrossRefGoogle Scholar
  36. 36.
    Kloting N, et al. (2008) Inverse relationship between obesity and FTO gene expression in visceral adipose tissue in humans. Diabetologia. 51:641–7.CrossRefGoogle Scholar
  37. 37.
    Elmquist JK, Ahima RS, Maratos-Flier E, Flier JS, Saper CB. (1997) Leptin activates neurons in ventrobasal hypothalamus and brainstem. Endocrinology. 138:839–42.CrossRefGoogle Scholar
  38. 38.
    Bates SH, et al. (2003) STAT3 signalling is required for leptin regulation of energy balance but not reproduction. Nature. 421:856–9.CrossRefGoogle Scholar
  39. 39.
    Hakansson ML, Meister B. (1998) Transcription factor STAT3 in leptin target neurons of the rat hypothalamus. Neuroendocrinology. 68:420–7.CrossRefGoogle Scholar
  40. 40.
    Greco SJ, et al. (2009) Leptin inhibits glycogen synthase kinase-3beta to prevent tau phosphory-lation in neuronal cells. Neurosci. Lett. 455:191–4.CrossRefPubMedCentralGoogle Scholar
  41. 41.
    Valerio A, et al. (2006) Leptin increases axonal growth cone size in developing mouse cortical neurons by convergent signals inactivating glycogen synthase kinase-3beta. J. Biol. Chem. 281:12950–8.CrossRefGoogle Scholar
  42. 42.
    Wang JH, et al. (2008) Leptin regulated calcium channels of neuropeptide Y and proopiome-lanocortin neurons by activation of different signal pathways. Neuroscience 156:89–98.CrossRefGoogle Scholar
  43. 43.
    Kloek C, et al. (2002) Regulation of Jak kinases by intracellular leptin receptor sequences. J. Biol. Chem. 277:41547–55.CrossRefGoogle Scholar
  44. 44.
    Escriva F, et al. (2007) Effect of age and moderate food restriction on insulin sensitivity in Wistar rats: role of adiposity. J. Endocrinol. 194:131–41.CrossRefGoogle Scholar
  45. 45.
    Carrascosa JM, Ros M, Andres A, Fernandez-Agullo T, Arribas C. (2009) Changes in the neuroendocrine control of energy homeostasis by adiposity signals during aging. Exp. Gerontol. 44:20–5.CrossRefGoogle Scholar
  46. 46.
    Church C, et al. (2010) Overexpression of Fto leads to increased food intake and results in obesity. Nat. Genet. 42:1086–92.CrossRefPubMedCentralGoogle Scholar
  47. 47.
    Stratigopoulos G, LeDuc CA, Cremona ML, Chung WK, Leibel RL. (2011) Cut-like homeobox 1 (CUX1) regulates expression of the fat mass and obesity-associated and retinitis pigmentosa GTPase regulator-interacting protein-1-like (RPGRIP1L) genes and coordinates leptin receptor signaling. J. Biol. Chem. 2011;286:2155–7.CrossRefGoogle Scholar
  48. 48.
    Tung YC, et al. (2010) Hypothalamic-specific manipulation of Fto, the ortholog of the human obesity gene FTO, affects food intake in rats. PLoS One. 5:e8771.CrossRefPubMedCentralGoogle Scholar

Copyright information

© The Feinstein Institute for Medical Research 2011

Authors and Affiliations

  • Pei Wang
    • 1
  • Feng-Jiao Yang
    • 1
  • Hui Du
    • 1
  • Yun-Feng Guan
    • 1
  • Tian-Ying Xu
    • 1
  • Xue-Wen Xu
    • 1
  • Ding-Feng Su
    • 1
  • Chao-Yu Miao
    • 1
    • 2
  1. 1.Department of PharmacologySecond Military Medical UniversityShanghaiChina
  2. 2.Shanghai Key Laboratory of Vascular Biology at Ruijin Hospital and Shanghai Institute of HypertensionShanghai Jiaotong University School of MedicineShanghaiChina

Personalised recommendations